| Autor: |
Satterstrom, F. K., Arcuri, A. S. A., Davis, T. A., Gulledge, W., Hansen, S. Foss, Haraza, M. A. Shafy, Kapustka, L., Karkan, D., Linkov, I., Melkonyan, M., Monica, J., Owen, R., Palma-Oliveira, J. M., Srdjevic, B. |
| Zdroj: |
Nanomaterials: Risks & Benefits; 2009, p329-350, 22p |
| Abstrakt: |
Many policy frameworks for risk assessment of manufactured nanomate-rials have been developed worldwide. These frameworks range from voluntary methods and self-regulation to prescriptive regulation. In our view, the regulatory policies ideally need to include consideration of the risks and benefits of nanotech-nology, as well as risk perception and risk communication efforts. Further, the policies should: (a) take a holistic viewpoint, considering the entire lifecycle of a manufactured nanomaterial, including use, production, transport, and disposal, and (b) consider the ecological and human health effects for all of the reasonably foreseeable exposures. There is a need for adaptive management to allow reaction to new developments (e.g., new toxicology information) and to gain additional information through policy.1–2 [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
